recall
saveCipla USA, Inc. recall (Cls III)
March 11, 2026updated 5mo ago
community read0 votes
Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, Outer carton: 112 capsules (4 individual packs containing 28 capsules each) NDC 69097-031-74; Inner carton: 28 capsules (4 blisters of 7 capsules) NDC 69097-031-56; Foil blister: NDC 69097-031-17 — Reason: Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test. — Status: Ongoing
view source ↗Data sources
last refreshed 26m ago
Found something off?
same company · ±60 days · 5
🐶 often sniffed alongside
top 8- tagRecall27 co-mentions · 16 sources
- companyCipla Ltd7 co-mentions · 5 sources
- druglanthanum carbonate6 co-mentions · 4 sources
- druglanreotide acetate6 co-mentions · 3 sources
- drugCINACALCET HYDROCHLORIDE6 co-mentions · 3 sources
- drugNILOTINIB4 co-mentions · 2 sources
- tagCRO/CDMO4 co-mentions · 2 sources
- companyInvaGen Pharmaceuticals Inc3 co-mentions · 2 sources
comments(0)
5-min edit window · permanent after that